IN2014MN02518A - - Google Patents
Info
- Publication number
- IN2014MN02518A IN2014MN02518A IN2518MUN2014A IN2014MN02518A IN 2014MN02518 A IN2014MN02518 A IN 2014MN02518A IN 2518MUN2014 A IN2518MUN2014 A IN 2518MUN2014A IN 2014MN02518 A IN2014MN02518 A IN 2014MN02518A
- Authority
- IN
- India
- Prior art keywords
- host cells
- ssi
- cho
- stable
- produce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261663147P | 2012-06-22 | 2012-06-22 | |
| EP12185330.3A EP2711428A1 (en) | 2012-09-21 | 2012-09-21 | Site-specific integration |
| PCT/EP2013/062859 WO2013190032A1 (en) | 2012-06-22 | 2013-06-20 | Site-specific integration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02518A true IN2014MN02518A (https=) | 2015-07-17 |
Family
ID=46888327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2518MUN2014 IN2014MN02518A (https=) | 2012-06-22 | 2013-06-20 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10280436B2 (https=) |
| EP (2) | EP2711428A1 (https=) |
| JP (1) | JP6053923B2 (https=) |
| KR (1) | KR101761709B1 (https=) |
| CN (1) | CN104379753B (https=) |
| AU (1) | AU2013279333C1 (https=) |
| BR (1) | BR112014032299B1 (https=) |
| CA (1) | CA2876280C (https=) |
| DK (1) | DK2864489T3 (https=) |
| EA (1) | EA034039B1 (https=) |
| ES (1) | ES2629509T3 (https=) |
| IL (1) | IL236347A0 (https=) |
| IN (1) | IN2014MN02518A (https=) |
| MX (1) | MX351727B (https=) |
| PL (1) | PL2864489T3 (https=) |
| SG (1) | SG11201408576QA (https=) |
| TW (1) | TWI523946B (https=) |
| WO (1) | WO2013190032A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201407852D0 (en) | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| HUE050105T2 (hu) * | 2015-04-27 | 2020-11-30 | Momenta Pharmaceuticals Inc | Eljárás terápiás protein gyártására |
| US11098310B2 (en) | 2016-01-27 | 2021-08-24 | Just-Evotec Biologics, Inc. | Expression from transposon-based vectors and uses |
| JP6937309B2 (ja) | 2016-01-27 | 2021-09-22 | ジャスト−エヴォテック バイオロジックス、インコーポレイテッド | ハイブリッドプロモーターおよびその使用 |
| US11261462B2 (en) | 2016-01-27 | 2022-03-01 | Just-Evotec Biologics, Inc. | Inducible expression from transposon-based vectors and uses |
| US11512144B2 (en) * | 2016-04-20 | 2022-11-29 | Regeneran Pharmaceuticals, Inc. | Compositions and methods for making antibodies based on use of an expression-enhancing loci |
| EA201892137A1 (ru) | 2016-04-20 | 2019-03-29 | Регенерон Фармасьютикалз, Инк. | Композиции и способы получения антител, основанные на применении локусов, обеспечивающих повышенную экспрессию |
| WO2018150269A1 (en) | 2017-02-17 | 2018-08-23 | Lonza Ltd. | Multi-site specific integration cells for difficult to express proteins |
| WO2018150271A1 (en) | 2017-02-17 | 2018-08-23 | Lonza Ltd. | Mammalian cells for producing adeno-associated viruses |
| GB201703418D0 (en) * | 2017-03-03 | 2017-04-19 | Ge Healthcare Bio Sciences Ab | Method for cell line development |
| EP3596206A1 (en) | 2017-03-16 | 2020-01-22 | Pfizer Inc | Tyrosine prototrophy |
| CN107557390A (zh) * | 2017-09-18 | 2018-01-09 | 江南大学 | 一种筛选cho细胞系高表达位点的方法 |
| IL275462B2 (en) * | 2017-12-22 | 2026-01-01 | Genentech Inc | Targeted integration of nucleic acids |
| JP7549582B2 (ja) * | 2018-10-01 | 2024-09-11 | ロンザ リミテッド | 予測可能かつ安定な導入遺伝子発現を有するｓｓｉ細胞および形成の方法 |
| EP3870604B1 (en) | 2018-10-26 | 2022-11-23 | F. Hoffmann-La Roche AG | Multispecific antibody screening method using recombinase mediated cassette exchange |
| AU2019403279A1 (en) * | 2018-12-21 | 2021-07-01 | Genentech, Inc. | Targeted integration of nucleic acids |
| KR102655024B1 (ko) | 2019-04-02 | 2024-04-04 | 추가이 세이야쿠 가부시키가이샤 | 표적 특이적인 외래 유전자의 도입 방법 |
| EP4058583A1 (en) | 2019-11-14 | 2022-09-21 | Lonza Ltd. | Methods of cell selection |
| KR102335242B1 (ko) | 2020-05-22 | 2021-12-02 | 인천대학교 산학협력단 | Fer1L4 유전자에 부위-특이적 통합된 RMCE 랜딩 패드를 포함하는 CHO 세포 |
| JP2023535604A (ja) | 2020-07-30 | 2023-08-18 | ファイザー・インク | 遺伝子複製を有する細胞およびその使用 |
| JP2024528139A (ja) | 2021-08-02 | 2024-07-26 | ファイザー・インク | 改良された発現ベクターおよびその使用 |
| AU2022373653A1 (en) | 2021-10-18 | 2024-05-02 | Regeneron Pharmaceuticals, Inc. | Eukaryotic cells comprising adenovirus-associated virus polynucleotides |
| US20250304911A1 (en) | 2022-02-02 | 2025-10-02 | Pfizer Inc. | Cysteine prototrophy |
| CN119955730A (zh) * | 2023-11-08 | 2025-05-09 | 深圳太力生物技术有限责任公司 | 一种细胞株及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| AU744445B2 (en) | 1997-04-24 | 2002-02-21 | University Of Washington | Targeted gene modification by parvoviral vectors |
| KR20070038556A (ko) * | 2004-07-20 | 2007-04-10 | 심포젠 에이/에스 | 항-ｒｈｅｓｕｓ ｄ 재조합 폴리클로날 항체 및 이의 제조방법 |
| JP4665115B2 (ja) * | 2004-08-06 | 2011-04-06 | 独立行政法人理化学研究所 | 骨・関節疾患感受性遺伝子およびその用途 |
| AU2006272634B2 (en) | 2005-07-26 | 2013-01-24 | Sangamo Therapeutics, Inc. | Targeted integration and expression of exogenous nucleic acid sequences |
-
2012
- 2012-09-21 EP EP12185330.3A patent/EP2711428A1/en not_active Withdrawn
-
2013
- 2013-06-20 BR BR112014032299-6A patent/BR112014032299B1/pt not_active IP Right Cessation
- 2013-06-20 ES ES13729962.4T patent/ES2629509T3/es active Active
- 2013-06-20 SG SG11201408576QA patent/SG11201408576QA/en unknown
- 2013-06-20 AU AU2013279333A patent/AU2013279333C1/en not_active Ceased
- 2013-06-20 CA CA2876280A patent/CA2876280C/en active Active
- 2013-06-20 PL PL13729962T patent/PL2864489T3/pl unknown
- 2013-06-20 EP EP13729962.4A patent/EP2864489B1/en active Active
- 2013-06-20 EA EA201590068A patent/EA034039B1/ru not_active IP Right Cessation
- 2013-06-20 CN CN201380032837.8A patent/CN104379753B/zh active Active
- 2013-06-20 WO PCT/EP2013/062859 patent/WO2013190032A1/en not_active Ceased
- 2013-06-20 MX MX2014015612A patent/MX351727B/es active IP Right Grant
- 2013-06-20 JP JP2015517758A patent/JP6053923B2/ja active Active
- 2013-06-20 US US14/409,283 patent/US10280436B2/en active Active
- 2013-06-20 IN IN2518MUN2014 patent/IN2014MN02518A/en unknown
- 2013-06-20 KR KR1020157000511A patent/KR101761709B1/ko active Active
- 2013-06-20 DK DK13729962.4T patent/DK2864489T3/en active
- 2013-06-21 TW TW102122188A patent/TWI523946B/zh not_active IP Right Cessation
-
2014
- 2014-12-18 IL IL236347A patent/IL236347A0/en active IP Right Grant
-
2018
- 2018-10-31 US US16/176,525 patent/US11326185B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02518A (https=) | ||
| PH12018501839A1 (en) | St2l antagonists and methods of use | |
| CR20140463A (es) | Compuestos de heterociclilo como inhibidores de mek | |
| UY34824A (es) | Nucleósidos de espirooxetano de uracilo | |
| MX363193B (es) | Metodos para tratar la dermatitis atopica mediante la administracion de un antagonista de il-4r. | |
| MY193481A (en) | Method and compositions comprising purified recombinant polypeptides | |
| MX2013008390A (es) | Preparacion de estructuras de metal-triazolato. | |
| ZA201401613B (en) | Method for producing highly pure platinum powder, as well as platinum powder that can be obtained according to said method, and use thereof | |
| UY34582A (es) | Anticuerpos anti-cxcr3 | |
| MX2020002544A (es) | Sales de glicopirrolato. | |
| PH12016500598A1 (en) | Protoxin-ii variants and methods of use | |
| IN2013DE00266A (https=) | ||
| MX379427B (es) | Proceso para la preparación de 4-hidroxi-4-metiltetrahidropiranos 2-sustituidos en una cascada de reactores. | |
| BR112014027219A2 (pt) | método | |
| ZA201600098B (en) | Plant produced human papillomavirus pseudovirion | |
| IN2015DN00085A (https=) | ||
| BR112014029620A2 (pt) | unidade de ventilação | |
| BR112015002145A2 (pt) | pino intramedular | |
| KR101560096B9 (ko) | 구조물의 수평, 수직도 조절 위한 트랜지션 피스 | |
| EP3022293A4 (en) | Methods for modeling chinese hamster ovary (cho) cell metabolism | |
| MX2019002801A (es) | Uso de una composicion farmaceutica que comprende un anticuerpo anti-il-4r en el tratamiento de la dermatitis atopica. | |
| GB201321642D0 (en) | Technique to enhance the coincidence of focussed, converging, light beams | |
| GT201200007S (es) | Dispositivo para iluminacion exterior (no.1) | |
| MX2016001694A (es) | Formulacion de vacuna de sacarido. | |
| AU347876S (en) | Adjustable spring base |